{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:42Z","timestamp":1707525162497},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,13]]},"DOI":"10.7759\/cureus.40365","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T14:26:19Z","timestamp":1686666379000},"source":"Crossref","is-referenced-by-count":0,"title":["Infection-Associated Mortality During Induction Chemotherapy in Group B Intermediate-Risk Pediatric Burkitt\u2019s Lymphoma"],"prefix":"10.7759","author":[{"given":"Syed Muhammad","family":"Ibne Ali Jaffari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masooma","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Wasey","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaha","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghufran","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arslan","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javeria","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muhammad Jawad","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehwish","family":"Kaneez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-019-0236-7","article-title":"The burden of Burkitt lymphoma in Africa","volume":"14","author":"H\u00e4mmerl L","year":"2019","unstructured":"H\u00e4mmerl L, Colombet M, Rochford R, Ogwang DM, Parkin DM. The burden of Burkitt lymphoma in Africa. Infect Agent Cancer. 2019, 14:17. 10.1186\/s13027-019-0236-7","journal-title":"Infect Agent Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v49i8.3908","article-title":"Childhood cancer in Pakistan","volume":"49","author":"Sohail Afzal M","year":"2020","unstructured":"Sohail Afzal M. Childhood cancer in Pakistan. Iran J Public Health. 2020, 49:1579. 10.18502\/ijph.v49i8.3908","journal-title":"Iran J Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181bdf1f3","article-title":"Pediatric lymphoma: a 10-year experience at a tertiary care hospital in Pakistan","volume":"32","author":"Fadoo Z","year":"2010","unstructured":"Fadoo Z, Belgaumi A, Alam M, Azam I, Naqvi A. Pediatric lymphoma: a 10-year experience at a tertiary care hospital in Pakistan. J Pediatr Hematol Oncol. 2010, 32:e14-8. 10.1097\/MPH.0b013e3181bdf1f3","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24407","article-title":"Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting","volume":"60","author":"Hesseling P","year":"2013","unstructured":"Hesseling P, Israels T, Harif M, Chantada G, Molyneux E. Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting. Pediatr Blood Cancer. 2013, 60:357-62. 10.1002\/pbc.24407","journal-title":"Pediatr Blood Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux EM","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, et al.. Burkitt's lymphoma. Lancet. 2012, 379:1234-1244. 10.1016\/S0140-6736(11)61177-X","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-022-02040-0","article-title":"The development and education of a workforce in childhood cancer services in low- and middle-income countries: a scoping review protocol","volume":"11","author":"Cayrol J","year":"2022","unstructured":"Cayrol J, Ilbawi A, Sullivan M, Gray A. The development and education of a workforce in childhood cancer services in low- and middle-income countries: a scoping review protocol. Syst Rev. 2022, 11:167. 10.1186\/s13643-022-02040-0","journal-title":"Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.3965","article-title":"Clinical course, long-term outcomes, and chemotherapy toxicity profile in B-cell non-Hodgkin lymphoma in children: single institution experience of Pakistan","volume":"72","author":"Rehman P","year":"2022","unstructured":"Rehman P, Wali RM. Clinical course, long-term outcomes, and chemotherapy toxicity profile in B-cell non-Hodgkin lymphoma in children: single institution experience of Pakistan. J Pak Med Assoc. 2022, 72:1988-93. 10.47391\/JPMA.3965","journal-title":"J Pak Med Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25810","article-title":"Improving care for children with cancer in low- and middle-income countries--a SIOP PODC initiative","volume":"63","author":"Arora RS","year":"2016","unstructured":"Arora RS, Challinor JM, Howard SC, Israels T. Improving care for children with cancer in low- and middle-income countries--a SIOP PODC initiative. Pediatr Blood Cancer. 2016, 63:387-91. 10.1002\/pbc.25810","journal-title":"Pediatr Blood Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-7563.2009.01264.x","article-title":"Clinical characteristics and outcome analysis of pediatric B-cell non-Hodgkin's lymphoma. Experience with FAB-LMB 96 and UKCCSG B-cell NHL guidelines in a developing country","volume":"6","author":"Ahmad N","year":"2010","unstructured":"Ahmad N, Zaidi A, Badar F, Maaz AU, Akram MS. Clinical characteristics and outcome analysis of pediatric B-cell non-Hodgkin's lymphoma. Experience with FAB-LMB 96 and UKCCSG B-cell NHL guidelines in a developing country. Asia Pac J Clin Oncol. 2010, 6:49-56. 10.1111\/j.1743-7563.2009.01264.x","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-017-2585-9","article-title":"Outcome of early stage pediatric non-lymphoblastic non-Hodgkin lymphoma","volume":"85","author":"Patel A","year":"2018","unstructured":"Patel A, Sharma MC, Bakhshi S. Outcome of early stage pediatric non-lymphoblastic non-Hodgkin lymphoma. Indian J Pediatr. 2018, 85:782-4. 10.1007\/s12098-017-2585-9","journal-title":"Indian J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phoj.2022.03.180","article-title":"High treatment related mortality due to infection remains a major challenge in the management of high-grade b-cell non-hodgkin lymphoma in children in developing countries: experience from a tertiary cancer center in Eastern India","volume":"7","author":"Mishra AK","year":"2022","unstructured":"Mishra AK, Krishnan S, Bhattacharyya A, et al.. High treatment related mortality due to infection remains a major challenge in the management of high-grade b-cell non-hodgkin lymphoma in children in developing countries: experience from a tertiary cancer center in Eastern India. Pediatr Hematol Oncol J. 2022, 7:54-60. 10.1016\/j.phoj.2022.03.180","journal-title":"Pediatr Hematol Oncol J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27621","article-title":"Outcome of pediatric non-Hodgkin lymphoma in Central America: a report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA)","volume":"66","author":"Pe\u00f1a-Hernandez A","year":"2019","unstructured":"Pe\u00f1a-Hernandez A, Ortiz R, Garrido C, et al.. Outcome of pediatric non-Hodgkin lymphoma in Central America: a report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA). Pediatr Blood Cancer. 2019, 66:e27621. 10.1002\/pbc.27621","journal-title":"Pediatr Blood Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.19.00172","article-title":"Advanced Burkitt lymphoma in Sub-saharan Africa pediatric units: results of the third prospective multicenter study of the Groupe Franco-Africain d'Oncologie P\u00e9diatrique","volume":"5","author":"Bouda GC","year":"2019","unstructured":"Bouda GC, Traor\u00e9 F, Couitchere L, et al.. Advanced Burkitt lymphoma in Sub-saharan Africa pediatric units: results of the third prospective multicenter study of the Groupe Franco-Africain d'Oncologie P\u00e9diatrique. J Glob Oncol. 2019, 5:1-9. 10.1200\/JGO.19.00172","journal-title":"J Glob Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/children8121086","article-title":"Update on febrile neutropenia in pediatric oncological patients undergoing chemotherapy","volume":"8","author":"Cennamo F","year":"2021","unstructured":"Cennamo F, Masetti R, Largo P, Argentiero A, Pession A, Esposito S. Update on febrile neutropenia in pediatric oncological patients undergoing chemotherapy. Children (Basel). 2021, 8:1086. 10.3390\/children8121086","journal-title":"Children (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/2049936113475610","article-title":"Management of febrile neutropenia in the era of bacterial resistance","volume":"1","author":"Alp S","year":"2013","unstructured":"Alp S, Akova M. Management of febrile neutropenia in the era of bacterial resistance. Ther Adv Infect Dis. 2013, 1:37-43. 10.1177\/2049936113475610","journal-title":"Ther Adv Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002178","article-title":"Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa","volume":"4","author":"Ozuah NW","year":"2020","unstructured":"Ozuah NW, Lubega J, Allen CE, El-Mallawany NK. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa. Blood Adv. 2020, 4:4007-19. 10.1182\/bloodadvances.2020002178","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/155211-infection-associated-mortality-during-induction-chemotherapy-in-group-b-intermediate-risk-pediatric-burkitts-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:00Z","timestamp":1707508920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/155211-infection-associated-mortality-during-induction-chemotherapy-in-group-b-intermediate-risk-pediatric-burkitts-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.40365","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,13]]}}}